Genome-wide association studies have identified breast cancer risk variants in over 150
genomic regions, but the mechanisms underlying risk remain largely unknown. These …

Breast cancer genome-wide association studies (GWASs) have identified 150 genomic risk
regions containing more than 13,000 credible causal variants (CCVs). The CCVs are …

The breast cancer risk variants identified in genome-wide association studies explain only a
small fraction of the familial relative risk, and the genes responsible for these associations …

Genome-wide association studies (GWASs) have identified more than 150 common genetic
loci for breast cancer risk. However, the target genes and underlying mechanisms remain …

Genome-wide association studies (GWAS) have identified more than 170 breast cancer
susceptibility loci. Here we hypothesize that some risk-associated variants might act in non …

Breast cancer is the most common cancer among women in the United States, with up to
30% of those diagnosed displaying a family history of breast cancer. To date, 18% of the …

Genome-wide association studies have identified 72 loci associated with breast cancer
susceptibility. Seventeen of these are known to predispose to other cancers. High …

Genome-wide association studies (GWAS) have identified approximately 100 breast cancer
risk loci. Translating these findings into a greater understanding of the mechanisms that …

Breast cancer is the most common cancer among women. Common variants at 27 loci have
been identified as associated with susceptibility to breast cancer, and these account for∼ …

Genome-wide association studies (GWAS) and large-scale replication studies have
identified common variants in 79 loci associated with breast cancer, explaining∼ 14% of the …